Health
Pig heart transplanted into human patient for the second time
Surgeons have transplanted a pig’s heart into a dying man in a bid to prolong his life – only the second patient to ever undergo such an experimental feat. Two days later, the man was cracking jokes and able to sit in a chair, Maryland doctors said Friday.
The 58-year-old Navy veteran was facing near-certain death from heart failure but other health problems meant he wasn’t eligible for a traditional heart transplant, according to doctors at University of Maryland Medicine, the Associated Press reported.
“Nobody knows from this point forward. At least now I have hope and I have a chance,” Lawrence Faucette, from Frederick, Maryland, said in a video recorded by the hospital before Wednesday’s operation. “I will fight tooth and nail for every breath I can take.”
While the next few weeks will be critical, doctors were thrilled at Faucette’s early response to the pig organ.
“You know, I just keep shaking my head – how am I talking to someone who has a pig heart?” Dr. Bartley Griffith, who performed the transplant, told The Associated Press. He said doctors are feeling “a great privilege but, you know, a lot of pressure.”
The same Maryland team last year performed the world’s first transplanet of a genetically modified pig heart into another dying man, David Bennett, who survived just two months.
There’s a huge shortage of human organs donated for transplant. Last year, there were just over 4,100 heart transplants in the U.S., a record number but the supply is so tight that only patients with the best chance of long-term survival get offered one.
Attempts at animal-to-human organ transplants have failed for decades, as people’s immune systems immediately destroyed the foreign tissue. Now scientists are trying again using pigs genetically modified to make their organs more humanlike.
Recently, scientists at other hospitals have tested pig kidneys and hearts in donated human bodies, hoping to learn enough to begin formal studies of what are called xenotransplants.
To make this new attempt in a living patient outside of a rigorous trial, the Maryland researchers required special permission from the Food and Drug Administration, under a process reserved for certain emergency cases with no other options.
It took over 300 pages of documents filed with FDA, but the Maryland researchers made their case that they’d learned enough from their first attempt last year – even though that patient died for reasons that aren’t fully understood – that it made sense to try again.
And Faucette, who retired as a lab technician at the National Institutes of Health, had to agree that he understood the procedure’s risks.
In a statement his wife, Ann Faucette, said: “We have no expectations other than hoping for more time together. That could be as simple as sitting on the front porch and having coffee together.”
What’s different this time: Only after last year’s transplant did scientists discover signs of a pig virus lurking inside the heart – and they now have better tests to look for hidden viruses. They also made some medication changes.
Possibly more important, while Faucette has end-stage heart failure and was out of other options, he wasn’t as near death as the prior patient.
By Friday, his new heart was functioning well without any supportive machinery, the hospital said.
“It’s just an amazing feeling to see this pig heart work in a human,” said Dr. Muhammad Mohiuddin, the Maryland team’s xenotransplantation expert. But, he cautioned, “we don’t want to predict anything. We will take every day as a victory and move forward.”
This kind of single-patient “compassionate use” can provide some information about how the pig organ works but not nearly as much as more formal testing, said Karen Maschke, a research scholar at the Hastings Center who is helping develop ethics and policy recommendations for xenotransplant clinical trials. That FDA allowed this second case “suggests that the agency is not ready to permit a pig heart clinical trial to start,” Mashke added.
The pig heart, provided by Blacksburg, Virginia-based Revivicor, has 10 genetic modifications – knocking out some pig genes and adding some human ones to make it more acceptable to the human immune system.
Health
Afghanistan, Uzbekistan move to expand cooperation in pharmaceutical sector
The two sides discussed expanding cooperation in the production and regulation of medicines and health products.
Afghanistan’s Ministry of Public Health has announced that Abdul Basir Qane, Director General of Drug and Health Products Regulation at the ministry’s Food and Drug Deputy, held talks with Uzbek health officials during his visit to Uzbekistan to strengthen bilateral cooperation in the pharmaceutical sector.
According to a statement issued by the ministry, Qane and his technical delegation met with Abdullah Azizov, head of Uzbekistan’s regulatory authority for medical and pharmaceutical industries, along with other senior officials.
The two sides discussed expanding cooperation in the production and regulation of medicines and health products, facilitating the entry of Uzbek pharmaceutical manufacturers into the Afghan market, implementing inspections in line with Good Manufacturing Practice (GMP) standards, streamlining the registration process for medicines, and increasing bilateral trade in pharmaceutical products.
The discussions also covered the development of laboratory infrastructure, capacity building and training for specialists, the exchange of expertise in regulatory and inspection fields, and broader technical and professional cooperation between the two countries.
At the conclusion of the meeting, both sides reaffirmed their commitment to strengthening long-term cooperation in the pharmaceutical and health products sector, supporting the activities of pharmaceutical companies in both markets, and continuing dialogue on mutually beneficial joint projects, the ministry said.
Health
Polio cases in Afghanistan rise to six in 2026 as two new cases confirmed
According to the WHO, one of the newly confirmed cases was identified in Nari district of Kunar province, while the other was reported in Nahr-e-Siraj district of Helmand province.
The World Health Organization (WHO) has announced that the number of confirmed polio cases in Afghanistan has risen to six in 2026, following the detection of two new infections in the country.
According to the WHO, one of the newly confirmed cases was identified in Nari district of Kunar province, while the other was reported in Nahr-e-Siraj district of Helmand province. The organization also stated that 34 positive environmental samples of wild poliovirus have been recorded in Afghanistan so far this year.
The report adds that in 2025, a total of 52 wild poliovirus type 1 cases were confirmed across Afghanistan and Pakistan, including 21 cases in Afghanistan and 31 in Pakistan.
WHO further noted that in 2026 so far, nine wild poliovirus type 1 cases have been reported across both countries, with six in Afghanistan and three in Pakistan.
Health experts say that low public awareness, resistance from some families to vaccination campaigns, and limited access to remote areas remain key factors behind the continued spread of the disease.
They emphasize that polio is incurable and vaccination is the only effective way to prevent infection.
Public health specialists also stress the need to expand immunization coverage, particularly in hard-to-reach areas, and to strengthen public awareness campaigns, warning that eradication efforts will remain difficult without broad community cooperation.
Afghanistan and Pakistan remain the only two countries in the world where wild poliovirus is still endemic and has not been fully eradicated.
Health
Health ministry urges greater public participation in blood donation
The appeal was made on Saturday as health officials marked World Blood Donor Day, an annual event aimed at raising awareness about the importance of voluntary blood donation and recognizing the contribution of donors in saving lives.
Afghanistan’s Ministry of Public Health has called on citizens to increase their participation in blood donation campaigns, warning that many patients still struggle to obtain compatible blood in emergencies despite improvements in the country’s blood management system.
The appeal was made on Saturday as health officials marked World Blood Donor Day, an annual event aimed at raising awareness about the importance of voluntary blood donation and recognizing the contribution of donors in saving lives.
Speaking at the ceremony, officials highlighted the critical role blood donors play in supporting the healthcare system and ensuring that hospitals have adequate supplies for patients requiring urgent treatment.
Abdul Wali Haqqani, Deputy Minister for Health Services at the Ministry of Public Health, said that shortages in blood reserves continue to pose challenges for healthcare providers, particularly when patients require specific blood types.
“Unfortunately, patients who need blood do not always have immediate access to compatible negative blood groups,” Haqqani said. “Blood donation is a simple yet invaluable humanitarian act. The World Health Organization recommends that at least one percent of a country’s population donate blood regularly to maintain sufficient reserves.”
Haqqani stressed that increasing public participation in blood donation could significantly improve the availability of life-saving blood supplies and strengthen healthcare services across the country.
Meanwhile, Wahdat Alkozi, Director of Curative Medicine at the ministry, said Afghanistan has made notable progress in blood management in recent years. He noted that standardized blood separation and storage systems are now operating at the Central Blood Bank and several regional hospitals.
“We are working to expand these systems throughout the country so that patients can have greater access to safe and standardized blood services,” Alkozi said.
According to officials from the Central Blood Bank, more than 220,000 units of blood were collected from voluntary donors over the past year. The blood was used in the treatment of more than 250,000 patients nationwide, underscoring the growing demand for blood supplies in hospitals and healthcare facilities.
However, Niazgul Niazmand, head of the Central Blood Bank, said the shortage of negative blood groups remains a major challenge due to the limited number of donors with those blood types.
Health experts emphasize that blood donation not only helps save the lives of accident victims, surgical patients, mothers experiencing childbirth complications, and individuals suffering from serious illnesses, but can also benefit donors by promoting healthy blood circulation and stimulating the production of new blood cells.
World Blood Donor Day is observed every year on June 14 to encourage voluntary blood donation and raise awareness about the ongoing need for safe blood and blood products around the world.
-
International Sports3 days agoKnockout picture begins to take shape at FIFA World Cup 2026
-
Latest News4 days agoContract signed for reconstruction of 15km section of Salang Highway
-
Business5 days agoKazakhstan signs $18.8 million zinc ore supply agreement with Afghan company
-
Latest News3 days agoAfghanistan’s SCO participation blocked over one member’s objection, Kabulov says
-
Latest News1 day agoTAPI project sees rapid progress in Afghanistan
-
Latest News4 days agoQatar embassy holds roundtable on Afghanistan’s relations with international community
-
Latest News3 days agoEU allocates 20 million euros to support returnees in Afghanistan
-
International Sports4 days agoMessi breaks World Cup scoring record as Argentina reach knockout stage
